Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)

View source ↗

Summary

This entry provides information about the RaDiCo Eurbio-Alport study, a RaDiCo cohort investigation sponsored by INSERM, which is currently recruiting for Alpor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Alport Syndrome | Status: RECRUITING